Sõda

MEEDIAVALVUR: algab „sõjalise erioperatsiooni“ teine etapp nimega „SÕDA“

Fourphit, also known as 4-isothiocyanato-PCP, is an irreversible dopamine transporter (DAT) blocker and a reversible NMDA receptor antagonist.[1][2] It blocks the binding of methylphenidate to the DAT in vitro,[1] though apparently not in vivo.[2] In any case, the drug reduces the stimulant-like effects of cocaine in animals,[2] whilst producing mostly negligible behavioral effects itself.[2] Fourphit is an acylating derivative of phencyclidine (PCP) and a positional isomer of metaphit (3-isothiocyanato-PCP).[1]

See also

References

  1. ^ a b c Schweri MM, Thurkauf A, Mattson MV, Rice KC (June 1992). "Fourphit: a selective probe for the methylphenidate binding site on the dopamine transporter". J Pharmacol Exp Ther. 261 (3): 936–942. PMID 1602399.
  2. ^ a b c d Schweri MM, de Costa BR, Rice KC (July 1998). "Fourphit, an acylating phencyclidine derivative, attenuates cocaine-induced hyperactivity in rats". Pharmacol Biochem Behav. 60 (3): 615–623. doi:10.1016/s0091-3057(98)00040-9. PMID 9678644.


Kommenteeri